Back to ACAD

BAKER BROS. ADVISORS LP → ACAD

BAKER BROS. ADVISORS LP ACAD Position History

Acadia Pharmaceuticals Inc. • Healthcare

Quarters held
4
Latest value
$864.7M
Q3 2026
Peak value
$1.1B
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$1.1B
Q1 2026$954.9M
Q2 2026$1.1B
Q3 2026$864.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$864.7M42.91M——
Q2 2026$1.1B42.91M——
Q1 2026$954.9M42.90M——
Q4 2025$1.1B42.90M——

Other funds holding ACAD

Other BAKER BROS. ADVISORS LP positions

INCY

Incyte Corporation

$3.7B
INCY

Incyte Corporation

$3.5B
BEIGF

BeOne Medicines Ltd.

$3.2B
INCY

Incyte Corporation

$3B
INCY

Incyte Corporation

$2.9B
BEIGF

BeOne Medicines Ltd.

$2.7B
BEIGF

BeOne Medicines Ltd.

$2.6B
BEIGF

BeOne Medicines Ltd.

$2.5B